famotidine
famotidine is listed in the FDA National Drug Code directory with 31 NDC codes, marketed under brand names including Acid Controller, acid reducer, careone acid relief. Available dosage forms: tablet, film coated, injection, solution, powder, for suspension.
Drug details
- Generic Name
- famotidine
- Brand Names
- Acid Controller, acid reducer, careone acid relief, ACID REDUCER, dg health acid reducer, heartburn relief, famotidine, Famotidine, acid relief, equate famotidine, Pepcid, dg health heartburn prevention, acid controller, FAMOTIDINE, basic care acid reducer, basic care heartburn prevention, topcare acid reducer
- Application Number
- ANDA077351
- Sponsor
- H E B
- NDC Codes
- 31
- Dosage Forms
- TABLET, FILM COATED, INJECTION, SOLUTION, POWDER, FOR SUSPENSION
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- FAMOTIDINE
Indications and Usage
1 INDICATIONS AND USAGE Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer (GU). • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Famotidine tablets are indicated in adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of duodenal ulcer recurrence. Famotidine is a histamine-2 (H 2 ) receptor antagonist indicated ( 1 ): In adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer. • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. In adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of DU recurrence.